PRF Technologies Ltd. logo

PRFX

NASDAQ

PRF Technologies Ltd.

SectorHealth CareIndustryBiotechnology: Pharmaceutical PreparationsIPO2020
Website
News25/Ratings0

PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.

News · 26 weeks38-100%
2025-10-26: 02025-11-02: 12025-11-09: 22025-11-16: 02025-11-23: 12025-11-30: 22025-12-07: 22025-12-14: 02025-12-21: 02025-12-28: 22026-01-04: 42026-01-11: 42026-01-18: 22026-01-25: 02026-02-01: 12026-02-08: 22026-02-15: 22026-02-22: 02026-03-01: 12026-03-08: 02026-03-15: 92026-03-22: 32026-03-29: 02026-04-05: 02026-04-12: 02026-04-19: 0
2025-10-262026-04-19
Mix1890d
  • Insider7(39%)
  • SEC Filings6(33%)
  • Other4(22%)
  • M&A1(6%)

Latest news

25 items